Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXX6I5
|
||||
Drug Name |
3-Acetyl-N-[1-(2S-ethyl-4-oxo-tetrahydro-furan-3S-ylcarbamoyl)-2S-(1-methyl-cyclopentyl)-ethyl]-4-methanesulfonylamino-benzamide
|
||||
Synonyms |
CHEMBL481227
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C25H35N3O7S
|
||||
Canonical SMILES |
CC[C@@H]1OCC(=O)[C@H]1NC(=O)[C@H](CC2(C)CCCC2)NC(=O)c3ccc(NS(=O)(=O)C)c(c3)C(=O)C
|
||||
InChI |
InChI=1S/C25H35N3O7S/c1-5-21-22(20(30)14-35-21)27-24(32)19(13-25(3)10-6-7-11-25)26-23(31)16-8-9-18(28-36(4,33)34)17(12-16)15(2)29/h8-9,12,19,21-22,28H,5-7,10-11,13-14H2,1-4H3,(H,26,31)(H,27,32)/t19-,21-,22+/m0/s1
|
||||
InChIKey |
JHYLMMFATBCMQI-ILWGZMRPSA-N
|
||||
Target and Pathway | |||||
Target(s) | Cathepsin K | Target Info | [1587926] | ||
Cathepsin L | Target Info | [1587926] | |||
Reactome | Collagen degradation | ||||
Degradation of the extracellular matrix | |||||
Activation of Matrix Metalloproteinases | |||||
Trafficking and processing of endosomal TLR | |||||
MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
Assembly of collagen fibrils and other multimeric structures | |||||
MHC class II antigen presentation | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.